Generic Treprostinil Available as Under-the-skin Injection
Sandoz‘s generic treprostinil injection now is available for subcutaneous (under-the-skin) administration to treat pulmonary arterial hypertension (PAH), the company announced in a press release. Treprostinil first was approved to treat PAH in the U.S. in 2002. It was developed by United Therapeutics, which markets the…